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by Norton Nelson*
One purpose ofthis meetingis to develop a series
of positions which will aid Sweden in making
certain decisions. It is not our purpose to make
engineering proposals or sociopolitical decisions; as
I understand it, we are being asked to make
technical judgments on the health implications of
emissions. These judgments will contribute, with
other sources of information, to the kinds of engi-
neering and sociopolitical decisions thatwill need to
be made.
In the most perfect situation, the product of our
deliberations willbe aclearandunambiguous series
ofstatementsonthehealthrisktohumansexpressed
in qualitative terms as to the nature of the health
injury to be expected, and for each such effect to
estimate quantitatively the probable impact on
human populations. Clearly, such a definitive out-
come is not going to be possible; we hope however,
to approximate it as nearly as is practicable.
Genotoxic effects, and especially cancer, are our
primary concerns. The inputs to this exercise
consist of epidemiological, laboratory and field
data. These sources are extremely uneven in rele-
vance, completeness and reliability. Part of our
taskwillbe to affix to each ofthese components and
their subcomponents, judgments as to their useful-
ness.
It is most unfortunate that epidemiological data
are so scanty; this is perhaps the most usual
situation. Indeed, it is in the very nature of our
efforts here to attempt to estimate a future epide-
miological outcome. Starting from the premise that
disease prevention is our objective, one would hope
thatanysubsequentepidemiologicalfollow-upbased
on our findings would yield substantially negative
results.
In approaching ourtask, we need, as aminimum,
to trace emissions from their point of discharge to
the critical target in humans, the critical target
being not merely the organ but the vulnerable
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biochemical unit, be it DNA or other cellular
component.
The collection of samples for test purposes,
whether analytical or biological, brings with it
possibilities of altering the chemical nature of the
materials during sampling; such possible artifacts
need to be clearly understood. It will be important
to give special attention to significant alterations in
emissions that occur after their discharge. This is
true both for diesel exhaust and power plant
effluents. Changes can occur during the movement
from the point of emission to the nose of exposed
humans;minimally, theseinvolve condensationand,
in some cases, chemical changes such as nitration
and oxidation. These need to be understood if
health-relevant predictions are to be attributed to
the emissions. In the same way, the extent of
condensation and the amount of vapor-phase poly-
nuclear aromatics (PNAs) need to be understood.
Since the materials appear to be largely particle-
bound, respirability of the particulates is also
significant. The reliability of the chemical charac-
terization of the materials in the emissions needs
meticulous review. There is obviously a whole
family of chemicals to be found in these particu-
lates, and some simplifying assumptions may be
required.
The question of bioavailability of the material
condensed or adsorbed on the carbon particles is a
further question regarding which information must
be sought. Next in the sequence of factors deter-
mining effective dosage is the pharmacokinetic
movement ofthe agents from the inhaled particles
to the critical biochemical unit within the cells of
target tissues.
With respect to the biological data, there are
available abundant data from short-term tests,
particularly bacterial revertants; there is also some
information on cell transformation. The translation
of this information into data relevant for humans
will be part of our chore. There is available a
growing body ofinformation on the biological tests
ofintermediate duration, such aslungadenoma and
initiation-promotion studies. Both willrequire care-
ful assessment.32 N. NELSON
The initiation-promotion studies have an addi-
tional nuance which could well engage our atten-
tion, since the multifactorial induction of cancer
must now be accepted as a frequent if not a usual
mode of cancer induction. Finally, in terms of
biological data, the results of long-term exposure
(by whatever route) to the particulates or extracts
is of vital consequence.
The merging of all this information and its
extrapolation must be undertaken. One must move
across species (except with respect to the epidemio-
logical data) and cover a wide span in terms of
dosage range; this transfer is almost certainly more
of a biological than a mathematical problem.
In examining this extensive body ofinformation,
we must also keep in mind the utility and relevance
of using data secured in analogous circumstances,
such as cigarette smoking and coke oven exposure,
for the particular problems examined here. The
employment of such analogous sources of informa-
tion can admittedly be tenuous; nevertheless, it can
also be, if appropriately used, a valuable way of
testing evidence secured from other sources.
Finally, I reiterate that during our endeavors,
we keep strictly in mind that our objective is to
analyze the available data and, from this, reach
judgments as to human risk; we should carefully
avoid placing ourselves in the role ofthe regulator.
We may, at anothertime and in a different context,
participate in such judgments, but if our technical
expertise is to be carried out in an objective and
dispassionate manner, we must recognize the need
tomaintainseparationbetweenscientificjudgments
and regulatory action.